Enhanced tumour uptake of radiolabelled antibodies by hyperthermia: Part I: Timing of injection relative to hyperthermia

References

• Huang Q, Hu JK, Lohr F, Zhang L, Braun R, Lanzen J, et al. Heat-induced gene expression as a novel targeted cancer gene therapy strategy. Cancer Res 2000;60:3435–3439.
   PubMed Web of Science ®Google Scholar
• Lohr F, Hu K, Huang Q, Zhang L, Sarnulski TV, Dewhirst MW, et al. Enhancement of radiotherapy by hyperthermia-regulated gene therapy. hit J Radiat Oncol Biol Phys 2000;48:1513–1518.
   PubMed Web of Science ®Google Scholar
• Brade AM, Ngo D, Szmitko P, Li PX, Liu FF, Klarnut HJ. Heat-directed gene targeting of adenoviral vectors to tumor cells. Cancer Gene Therapy 2000;7:1566–1574.
   PubMed Web of Science ®Google Scholar
• Braiden V, Ohtsuru A, Kawashita Y, Miki F, Sawada T, Ito M, et al. Eradication of breast cancer xenografts by hyperthermic suicide gene therapy under the control of the heat shock protein promoter. Human Gene Therapy 2000;11:2453–2463.
   PubMed Web of Science ®Google Scholar
• Tsujino I, Anderson GS, Sieber F. Postirradiation hyperthermia selectively potentiates the merocyanine 540-sensitized photoinactivation of small cell lung cancer cells. Photochemistry & Photobiology 2000;73: 191–198.
   Google Scholar
• Uehara M, Inokuchi T, Sano K. Experimental study of combined hyperthermic and photodynamic therapy on carcinoma in the mouse. J Oral Maxillofacial Sur 1996;54:729–736.
   Google Scholar
• van Hillegersberg R, Kort WJ, Wilson JH. Current status of photodynamic therapy in oncology. Drugs 1994;48:510–527.
   Google Scholar
• Baron S, Tyring SK, Fleischmann WR, Jr., Coppenhaver DH, Niesel DW, Klimpel GR, et al. The interferons. Mechanisms of action and clinical applications. JANIA 1991;266:1375–1383.
   Google Scholar
• Ceelen WP, Hesse U, de Hemptinne B, Pattyn P. Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intra-abdominal cancer. Br J Surg 2000;87:1006–1015.
   PubMed Web of Science ®Google Scholar
• Horsman MR, Murata R, Breidahl T, Nielsen FU, Maxwell RJ, Stodkiled-Jorgensen H, et al. Combretastatins novel vascular targeting drugs for improving anti-cancer therapy. Combretastatins and conventional therapy. Adv Exp Med Biol 2000;476:311–323.
   Google Scholar
• Takada N. Effects of combination therapy with hyperthermia and immuno-targeting chemotherapy using anti-AFP antigen on hepatocellular carcinoma. Hokkaido J Med Sci 1990;65:384–391.
   PubMedGoogle Scholar
• Kong G, Dewhirst MW. Hyperthermia and liposomes: A review. Int J Hyperthermia 1999;15:345–370.
   PubMed Web of Science ®Google Scholar
• Needham D, Anyarambhatla G, Kong G, Dewhirst MW. New temperature-sensitive liposome for use with mild hyperthermia: Characterization and testing in a human tumor xenograft model. Cancer Res 2000;60:1197–1201.
   PubMed Web of Science ®Google Scholar
• Bast RC, Zalutsky MR, Frankel AE. Monoclonal serotherapy. In: Holland JF, Frei E, Bast RC, Kufe DW, Morton DL, Weichselbaum RR, editors. Cancer Medicine, 3rd edn. Vol. 1. Philadelphia, PA: Lea & Febiger; 1993. pp. 68–82.
   Google Scholar
• Antoniw P, Farnsworth APH, Turner A, Haines AMR, Mountain A, Mackintosh J, et al. Radioimmunotherapy of colorectal carcinoma xenografts in nude mice with yttirum-90 A33 IgG and Tr-Fab (TFM). Br J Cancer Res 1996;74:513–524.
   PubMedGoogle Scholar
• Epenetos AA, Nimmon CC, Arklie J, Elliott AT, Hawkins LA, Knowles RW, et al. Detection of human cancer in an animal model using radio-labelled tumour-associated monoclonal antibodies. Br J Cancer 1982;46:1–8.
   PubMed Web of Science ®Google Scholar
• Ward BG, Wallace K. Localization of the monoclonal antibody HMFG2 after intravenous and intraperitoneal injection into nude mice bearing subcutaneous and intraperitoneal human ovarian cancer xenografts. Cancer Res 1987;47:4714–4718.
   PubMedGoogle Scholar
• Moldofsky PJ, Powe J, Mulhem CB, Hammond N, Sears HF, Gatenby RA, et al. Metastatic colon carcinoma detected with radiolabeled F(Ab')2 monoclonal antibody fragments. Radiology 1983;149:549–555.
   PubMed Web of Science ®Google Scholar
• Miraldi FK, Nelson AD, Kraly C, Ellery S, Landmeir B, Coccia PF, et al. Diagnostic imaging of human neuroblastoma with radiolabeled antitumor antibody. Radiology 1986;161:413–417.
   PubMed Web of Science ®Google Scholar
• Colcher D, Esteban J, Carrasquillo JA, Sugarbaker P, Reynolds JC, Bryant G, et al. Quantitative analyses of selective radiolabeled monoclonal antibody localization in metastatic lesions of colorectal cancer patients. Cancer Res 1987;47:1185–1189.
   PubMed Web of Science ®Google Scholar
• Page RL, Garg PK, Garg S, Archer GE, Bruland OS, Zalutsky MR. PET imaging of osteosarcoma in dogs using a fluorine-18-labeled monoclonal antibody Fab fragment. J Nucl Med 1994;35:1506–1513.
   PubMed Web of Science ®Google Scholar
• Foulon CF, Reist CJ, Bigner DD, Zalutsky MR Radioiodination via D-amino acid peptide enhances cellular retention and tumor xenograft targeting of an internalizing anti-epidermal growth factor receptor variant III monoclonal antibody. Cancer Res 2000;60:4453–4460.
   PubMed Web of Science ®Google Scholar
• Hauck ML, Dewhirst MW, Bigner DD, Zalutsky MR. Local hyperthermia improves uptake of a chimeric monoclonal antibody in a subcutaneous xenograft model. Chin Cancer Res 1997;3:63–70.
   Google Scholar
• Cope DA, Dewhirst MW, Friedman HS, Bigner DD, Zalutsky MR. Enhanced delivery of a monoclonal antibody F(Ab')2 fragment to subcutaneous human glioma xenografts using local hyperthermia. Cancer Res 1990;50: 1803–1809.
   Google Scholar
• Hosono MN, Hosono M, Endo K, Ueda R, Onoyarna Y. Effect of hyperthermia on tumor uptake of radiolabeled anti-neural cell adhesion molecule antibody in small-cell lung cancer xenografts. J Nucl Med 1994;35:504–509.
   Google Scholar
• Schuster JM, Zalutsky MR, Noska MA, Dodge R, Friedman HS, Bigner DD, et al. Hyperthermic modulation of radiolabelled antibody uptake in a human glioma xenograft and normal tissues. Int J Hyperthermia 1995;11:59–72.
   PubMed Web of Science ®Google Scholar
• Stickney DR, Gridley DS, Kirk GA, Slater JM. Enhancement of monoclonal antibody binding to melanoma with single dose radiation or hyperthermia. Natl Cancer Inst Monogr 1987;3:47–52.
   Google Scholar
• Bigner DD, Brown MT, Friedman AH, Coleman RE, Akabani G, Friedman HS, et al. Iodine-131-labeled anti-tenascin monoclonal antibody 8106 treatment of patients with recurrent malignant gliomas: Phase I trial results. J Chin Oncol 1998;16:2202–2212.
   PubMed Web of Science ®Google Scholar
• Wikstrand CJ, McLendon RE, Carrel S, Kemshead JT, Mach J.-P, Coakham HB, et al. Comparative localization of glioma-reactive monoclonal antibodies in vivo in an athymic mouse human glioma xenograft model. J Neuroimmunol 1987;15:37–56.
   Google Scholar
• Murphy-Ullrich JE, Lighmer VA, Aukhil I, Zan YZ, Erickson HP, Hook M. Focal adhesion integrity is downregulated by the alternatively spliced domain of human tenascin. J Cell Biol 1991;115:1127–1136.
   Google Scholar
• Bourdon MA, Wikstrand CJ, Furthmayr H, Matthews TJ, Bigner DD. Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody. Cancer Res 1983;43:2796–2805.
   Google Scholar
• He X, Archer GE, Wikstrand CJ, Morrison SL, Zalutsky MR, Bigner DD, et al. Generation and characterization of a mouse/human chimeric antibody directed against extracellular matrix protein tenascin. J Neuroimmunol 1994;52:127–137.
   PubMedGoogle Scholar
• Dangl JL, Wensel TG, Morrison SL, Stryer L, Herzenberg LA, Oi VT. Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies. EMBO J 1988;7:1989–1994.
   PubMed Web of Science ®Google Scholar
• Bullard DE, Schold SC, Bigner SH, Bigner DD. Growth and chemotherapeutic response in athymic mice of tumors arising from human glioma-derived cell lines. Neuropathol Exp Neurol 1981;40:410–427.
   PubMed Web of Science ®Google Scholar
• Fraker PJ, Speck JC. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril. Biochem Biophys Res Commun 1978;80:849–857.
   PubMed Web of Science ®Google Scholar
• Msirikale JS, Klein JL, Schroeder J, Order SE. Radiation enhancement of radiolabelled antibody deposition in tumors. Int J Radiat Oncol Biol Phys 1987;13:1839–1844.
   PubMed Web of Science ®Google Scholar
• Wong JYC, Williams LE, Hill LR, Paxton RJ, Beatty BG, Shively JE, et al. The effects of tumor mass, tumor age, and external beam radiation on tumor-specific antibody uptake. Int J Radiat Oncol Biol Phys 1989;16:715–720.
   PubMedGoogle Scholar
• Shrivastav S, Schlom J, Raubitschek A, Molinolo A, Simpson J, Horan Hand P. Studies concerning the effect of external irradiation on localization of radiolabeled monoclonal antibody B72.3 to human colon carcinoma xenografts. hit J Radiat Oncol Biol Phys 1989;16: 721–729.
   Google Scholar
• Gridley DS, Ewart KL, Cao JD, Stickney DR. Hyperthermia enhances localization of "In-labeled hapten to bifunctional antibody in human colon tumor xenografts. Cancer Res 1991;51:1515–1520.
   PubMed Web of Science ®Google Scholar
• Khawli LA, Miller GK, Epstein AL. Effect of seven new vasoactive immunoconjugates on the enhancement of monoclonal antibody uptake in tumors. Cancer; 73:824–831.
   Google Scholar
• Thak-ur ML, DeFulvio J, Tong J, John E, McDevitt MR, Damjanov I. Evaluation of biological response modifiers in the enhancement of tumor uptake of technetium-99m labeled macromolecules. J Immunol Methods 1992;152: 209–216.
   Google Scholar
• Rowlinson-Busza G, Maraveyas A, Epenetos AA. Effect of tumour necrosis factor on the uptake of specific and control monoclonal antibodies in a human tumour xenograft model. Br J Cancer 1995;71:660–665.
   Google Scholar
• Thrall DE, Rosner GL, Azuma C, LaRue SM, Case BC, Samulski TV, et al. Using units of CEM43°CT90, local hyperthermia thermal dose can be delivered as prescribed. hit J Hyperthermia 2000;16:415–428.
   PubMed Web of Science ®Google Scholar
• Zalutsky MR, Lewis J. Radiolabeled antibodies for tumor imaging and therapy. In: Welch MJ, Redvanly C, editors. Handbook of radiopharmaceuticals: Radiochemistry and applications. Chichester, UK: Wiley; 2003. pp. 685–713.
   Google Scholar
• Zalutsky MR, Vaidyanathan G. Astatine-211-labeled radiotherapeutics: An emerging approach to targeted alpha particle therapy. Current Pharm Design 2000;6:1433–1455.
   PubMed Web of Science ®Google Scholar
• Covell DG, Barbet J, Holton OD, Black CDV, Parker RJ, Weinstein JN. Pharmacokinetics of monoclonal immunoglobulin GI, F(Ab')2, and Fab' in mice. Cancer Res 1986;46:3969–3978.
   PubMed Web of Science ®Google Scholar
• Kong G, Braun RD, Dewhirst MW. Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature. Cancer Res 2001;61:3027–3032.
   Google Scholar